Skip to main content

Table 2 Subgroup analysis of four IR surrogates differences between non-hypertensive and hypertensive groups

From: Comparison of the predictive value of four insulin resistance surrogates for the prevalence of hypertension: a population-based study

 

Non-hypertension

Hypertension

p-value

Non-hypertension

Hypertension

p-value

Gender

Male

 

Female

 

 TG/HDL-c

2.02 (1.35–3.12)

2.01 (1.34–3.08)

0.104

1.76 (1.18–2.70)

1.83 (1.23–2.79)

 < 0.001

 TyG index

8.37 (7.99–8.79)

8.41 (8.03–8.83)

 < 0.001

8.36 (7.98–8.77)

8.42 (8.04–8.82)

 < 0.001

 TyG-BMI

200.29 (181.34–220.96)

214.94 (195.43–236.06)

 < 0.001

180.81 (164.14–200.30)

204.27 (183.97–226.61)

 < 0.001

 METS-IR

34.87 (31.35–38.67)

37.35 (33.76–41.28)

 < 0.001

30.31 (27.4–33.88)

34.63 (30.94–38.64)

 < 0.001

AST

 < 40 U/L

 

 ≥ 40 U/L

 

 TG/HDL-c

1.88 (1.26–2.87)

1.92 (1.29–2.94)

0.005

1.97 (1.32–3.05)

2.04 (1.36–3.13)

0.274

 TyG index

8.37 (7.99–8.78)

8.43 (8.05–8.83)

 < 0.001

8.39 (8.0–8.8)

8.45 (8.09–8.87)

0.006

 TyG-BMI

190.99 (171.66–211.84)

210.27 (190.74–231.11)

 < 0.001

211.3 (189.7–233.62)

231.67 (207.55–256.37)

 < 0.001

 METS-IR

32.65 (29.09–36.57)

36.15 (32.59–40.07)

 < 0.001

36.71 (32.49–41.04)

39.86 (35.95–44.41)

 < 0.001

ALT

 < 40 U/L

 

 ≥ 40 U/L

 

 TG/HDL-c

1.87 (1.25–2.88)

1.92 (1.29–2.95)

 < 0.001

2.06 (1.38–3.15)

2.06 (1.39–3.16)

0.720

 TyG index

8.36 (7.98–8.78)

8.41 (8.03–8.83)

 < 0.001

8.39 (8.0–8.80)

8.42 (8.07–8.81)

0.002

 TyG-BMI

188.44 (169.63–208.89)

208.01 (188.70–228.93)

 < 0.001

213.98 (194.32–234.96)

229.28 (209.32–251.46)

 < 0.001

 METS-IR

32.13 (28.65–36.04)

35.82 (32.20–39.66)

 < 0.001

37.55 (33.76–41.53)

40.04 (36.3–44.5)

 < 0.001

BMI

 < 24 kg/m2

24–28 kg/m2

 ≥ 28 kg/m2

 

non-Hypertension

Hypertension

p-value

non-Hypertension

Hypertension

p-value

non-Hypertension

Hypertension

p-value

 TG/HDL-c

1.81 (1.21–2.79)

1.84 (1.23–2.82)

0.221

2.02 (1.35–3.12)

2 (1.34–3.07)

0.101

2.08 (1.39–3.23)

2.04 (1.36–3.13)

0.037

 TyG index

8.35 (7.97–8.77)

8.4 (8.01–8.81)

 < 0.001

8.4 (8.0–8.81)

8.42 (8.05–8.84)

 < 0.001

8.4 (8.03–8.81)

8.42 (8.05–8.82)

0.136

 TyG-BMI

177.08 (163.1–190.9)

185 (172.4–197.1)

 < 0.001

214 (205.6–229.6)

217.2 (205.6–229.6)

 < 0.001

248.82 (235.2–264.7)

251.7 (238–268.7)

 < 0.001

 METS-IR

30 (27.45–32.49)

31.54 (29.21–33.6)

 < 0.001

37.2 (35.2–39.5)

37.5 (35.5–39.8)

 < 0.001

43.59 (41.22–46.68)

43.99 (41.3–47)

0.001

Age

 ≤ 44 year

45–59 year

 ≥ 60 year

 

non-Hypertension

Hypertension

p-value

non-Hypertension

Hypertension

p-value

non-Hypertension

Hypertension

p-value

 TG/HDL-c

1.88 (1.26–2.90)

1.99 (1.33–3.04)

 < 0.001

1.92 (1.27–2.95)

1.94 (1.30–3.0)

0.094

1.87 (1.26–2.89)

1.93 (1.3–2.94)

 < 0.001

 TyG index

8.35 (7.97–8.76)

8.37 (8.0–8.79)

0.001

8.4 (8.01–8.81)

8.41 (8.05–8.83)

0.007

8.41 (8.03–8.83)

8.45 (8.06–8.85)

0.001

 TyG-BMI

186.3 (167.15–208.1)

213.5 (191.1–238)

 < 0.001

197.3 (179.2–217.3)

212.7 (192–233.6)

 < 0.001

200.1 (181.58–229.6)

208.9 (190–229.6)

 < 0.001

 METS-IR

31.79 (29.23–36.04)

37 (32.83–41.64)

 < 0.001

33.78 (30.36–37.58)

36.62 (33.08–40.5)

 < 0.001

34.31 (30.71–38.08)

36 (32.4–39.79)

 < 0.001

  1. IR insulin resistance,TG triglyceride, HDL-c high-density lipoprotein cholestero, ALT alanine aminotransferas, AST aspartate aminotransferas, BMI Body mass inde, TG/HDL-c triglycerides/high-density lipoprotein cholesterol rati, TyG index Triglyceride-glucose inde, TyG-BMI TyG index with body mass inde, METS-IR metabolic score for insulin resistance